Clinical Trial Technology Editorial
-
Insights Into TMF Challenges & Solutions — Part 1
6/26/2024
This is part one of a two-part Q&A I did with Nicole Palmer about a variety of issues surrounding the trial master file (TMF). In this part, she talks about the TMF Reference Model, moving to an eISF, and challenges with e-signatures.
-
The Future Of Epilepsy Research And Transformative Treatments
6/12/2024
UCB's Head of Epilepsy and Rare Syndromes discusses the future of epilepsy treatment and clinical trials.
-
Digitalized Drug Forecasting Minimizes Waste In Clinical Trial Supply Chain
6/5/2024
Why should pharma companies strive for more sustainable clinical trials? And how can digitalizing drug forecasting reduce waste in the supply chain? J&J Innovative Medicine's Kristel Rens explains.
-
How IRBs Can Keep Up With the Rest Of The Clinical Research Industry
5/29/2024
Univo IRB CEO Julie Blasingim explores the new era of IRBs and how they can leverage technology to stay on pace with and meet the needs of the rest of the clinical research industry.
-
The Best Advice I Ever Got: On The Job
5/22/2024
To commemorate Clinical Trials Day 2024, Clinical Leader tapped its community of clinical research professionals to share their insights — from individual efforts to partnership best practices to trial design and more.
-
Unlocking Next Generation Clinical Trials Through Data Sharing & Tech-Driven Approaches
5/21/2024
New findings from a survey conducted in the U.S. indicate a significant number of trial participants are eager to have their data used by researchers. How can biopharma companies harness this?
-
Competitors Need To Collaborate On Digital Biomarkers
5/15/2024
Regeneron’s second annual Digital Biomarkers Summit is a good example of how competing pharma companies can work together in a noncompetitive environment for the industrywide goal of advancing the use of digital biomarkers in clinical trials.
-
What Can Digital Patient Twins Do For Clinical Research?
4/29/2024
Digital patient twins have the potential to vastly improve our current healthcare systems by offering personalized therapeutics, enhanced health monitoring, and streamlined pharmaceutical manufacturing, including clinical trials.
-
Ignoring Digital Biomarkers Will Be Your Undoing
4/12/2024
We are still in the early days of uncovering all the advantages of digital biomarkers. “It’s difficult to figure out what you can measure repeatedly and with some sense of validity,” says Bari Kowal, SVP, development operations, portfolio management & biostatistics data management at Regeneron.
-
Dear Data Analysts, AI Is Not Replacing You
4/2/2024
Deep beneath the ongoing narrative of AI’s potential use cases in clinical trials is the same fear that persists in other industries facing a technology revolution. Will jobs be lost and replaced by machines? So, I thought I’d ask an expert — a machine.